Format

Send to

Choose Destination
See comment in PubMed Commons below
JOP. 2013 Jul 10;14(4):347-53. doi: 10.6092/1590-8577/1646.

Advances in immunotherapy for pancreatic cancer: 2013.

Author information

1
Tufts Medical Center. Boston, MA 02111, USA. ndevito@tuftsmedicalcenter.org

Abstract

Pancreatic cancer is one of the more difficult malignancies to treat, and there is a great need for less toxic, effective regimens. Immunotherapy has shown potential in the treatment of pancreatic cancer, and at ASCO 2013 there were several progressive advances in its clinical application. Abstracts #3067, #3049, #3007, #4040, #LBA4004, and #3090 will be discussed. New developments in the field of immunotherapy are promising novel treatments for pancreatic neoplasms with tolerable side effect profiles.

PMID:
23846925
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for JOP. Journal of the Pancreas (Online)
    Loading ...
    Support Center